Literature DB >> 18418862

Immunoglobulin G4-related sclerosing cholangitis in patients resected for presumed malignant bile duct strictures.

D Erdogan1, J J Kloek, F J W ten Kate, E A J Rauws, O R C Busch, D J Gouma, T M van Gulik.   

Abstract

BACKGROUND: Immunoglobulin (Ig) G(4)-related lymphoplasmacytic sclerosing pancreatitis has been described in the context of autoimmune pancreatitis mimicking distal cholangiocarcinoma. The aim of this study was to assess the occurrence of this entity in benign bile duct strictures in patients resected for presumed hilar cholangiocarcinoma.
METHODS: Of 185 patients who had undergone resection of proximal bile ducts on suspicion of hilar cholangiocarcinoma between January 1984 and June 2005, 32 (17.3 per cent) had a benign bile duct stricture on histopathological examination. After re-evaluation, further immunohistochemical analysis was performed on specimens from patients with features of autoimmune-like disease.
RESULTS: The periductal stroma in 15 patients showed features of autoimmune-like disease (diffuse, moderate to severe lymphoplasmacytic infiltration with marked fibrosis). Abundant IgG(4)-positive plasma cell infiltration around the bile duct lesions was seen in two of these. Although not significant, patients with features of autoimmune-like disease on histological changes showed a higher incidence of recurrent biliary complications than those without (P = 0.250).
CONCLUSION: Features of autoimmune-like bile duct disease were seen in almost half (15 of 32) of patients with benign hilar strictures resected for presumed hilar cholangiocarcinoma. Frank IgG(4)-related sclerosing disease was found in only two of the 15 patients with autoimmune-like bile duct disease. 2008 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18418862     DOI: 10.1002/bjs.6057

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  37 in total

1.  Comparison of CT findings of biliary tract changes with autoimmune pancreatitis and extrahepatic bile duct cholangiocarcinoma.

Authors:  Eriko Maeda; Masaaki Akahane; Naoki Yoshioka; Hidemasa Takao; Izuru Matsuda; Kouhei Kamiya; Kenji Hirano; Minoru Tada; Hiroshi Ohtsu; Noriyoshi Fukushima; Kuni Ohtomo
Journal:  Jpn J Radiol       Date:  2011-12-27       Impact factor: 2.374

2.  Preoperative Risk Score to Predict Occult Metastatic or Locally Advanced Disease in Patients with Resectable Perihilar Cholangiocarcinoma on Imaging.

Authors:  Jimme K Wiggers; Bas Groot Koerkamp; David van Klaveren; Robert J Coelen; C Yung Nio; Peter J Allen; Marc G Besselink; Olivier R Busch; Michael I D'Angelica; Ronald P DeMatteo; T Peter Kingham; Thomas M van Gulik; William R Jarnagin
Journal:  J Am Coll Surg       Date:  2018-04-06       Impact factor: 6.113

3.  Differentiation of malignant and benign proximal bile duct strictures: the diagnostic dilemma.

Authors:  Jaap Jacob Kloek; Otto Marinus van Delden; Deha Erdogan; Fibo Jan ten Kate; Erik Anthoni Rauws; Olivier-Robert Busch; Dirk Joan Gouma; Thomas Mathijs van Gulik
Journal:  World J Gastroenterol       Date:  2008-08-28       Impact factor: 5.742

4.  Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-associated cholangitis from cholangiocarcinoma.

Authors:  Abdul M Oseini; Roongruedee Chaiteerakij; Abdirashid M Shire; Amaar Ghazale; Joseph Kaiya; Catherine D Moser; Ileana Aderca; Teresa A Mettler; Terry M Therneau; Lizhi Zhang; Naoki Takahashi; Suresh T Chari; Lewis R Roberts
Journal:  Hepatology       Date:  2011-08-08       Impact factor: 17.425

Review 5.  Diagnosis and management of IgG4-related disease.

Authors:  Vinod S Hegade; Maria B Sheridan; Matthew T Huggett
Journal:  Frontline Gastroenterol       Date:  2018-10-31

Review 6.  The current diagnosis and treatment of benign biliary stricture.

Authors:  Hiroshi Shimada; Itaru Endo; Kazuhiro Shimada; Ryusei Matsuyama; Noritoshi Kobayashi; Kensuke Kubota
Journal:  Surg Today       Date:  2012-09-22       Impact factor: 2.549

Review 7.  IgG4-associated cholangitis: a comprehensive review.

Authors:  Lowiek M Hubers; Lucas J Maillette de Buy Wenniger; Marieke E Doorenspleet; Paul L Klarenbeek; Joanne Verheij; Erik A Rauws; Thomas M van Gulik; Ronald P J Oude Elferink; Stan F J van de Graaf; Niek de Vries; Ulrich Beuers
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

8.  Hilar cholangiocarcinoma: preoperative liver optimization with multidisciplinary approach. Toward a better outcome.

Authors:  Francesca Ratti; Federica Cipriani; Fabio Ferla; Marco Catena; Michele Paganelli; Luca A M Aldrighetti
Journal:  World J Surg       Date:  2013-06       Impact factor: 3.352

Review 9.  IgG4-related hepatobiliary disease: an overview.

Authors:  Emma L Culver; Roger W Chapman
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-09-14       Impact factor: 46.802

Review 10.  Usefulness of steroid administration for diagnosis of IgG4-related sclerosing cholangitis.

Authors:  Norio Kubo; Hideki Suzuki; Tsutomu Kobayashi; Kenichiro Araki; Shigeru Sasaki; Wataru Wada; Hiroyuki Kuwano
Journal:  Int Surg       Date:  2012 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.